Clinical impact of Internet-based tools to guide therapeutic decisions for mantle cell lymphoma

Srinivasa N. Gopalsamy, Kristen M. Rosenthal, Amy A. Ayers, Andre Goy, John P. Leonard, Julie M. Vose, Kevin L. Obholz, James O. Armitage, Christopher R. Flowers

Research output: Contribution to journalArticle

Abstract

Mantle cell lymphoma (MCL) is a rare cancer with diverse management options. Although clinical practice guidelines have become ubiquitous across medicine, the utility of guidelines for MCL management is limited by provider awareness and the lack of a definitive standard of care. We sought to determine whether expert recommendations, delivered as an online decision support tool, impacted practitioners’ therapeutic decisions with MCL. Participants were more likely than the experts to select aggressive regimens for both newly diagnosed and relapsed/refractory MCL. After seeing the expert recommendations, participants revealed that the expert opinion impacted their treatment choices in 103 of 365 clinical scenarios, suggesting that online decision support tools may increase the number of clinicians making treatment decisions for patients with MCL that are concordant with expert consensus recommendations.

Original languageEnglish (US)
Pages (from-to)2255-2263
Number of pages9
JournalLeukemia and Lymphoma
Volume60
Issue number9
DOIs
StatePublished - Jul 29 2019

Fingerprint

Mantle-Cell Lymphoma
Internet
Therapeutics
Expert Testimony
Standard of Care
Practice Guidelines
Consensus
Decision Making
Medicine
Guidelines
Neoplasms

Keywords

  • Mantle cell lymphoma
  • clinical decision support
  • decision making

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Gopalsamy, S. N., Rosenthal, K. M., Ayers, A. A., Goy, A., Leonard, J. P., Vose, J. M., ... Flowers, C. R. (2019). Clinical impact of Internet-based tools to guide therapeutic decisions for mantle cell lymphoma. Leukemia and Lymphoma, 60(9), 2255-2263. https://doi.org/10.1080/10428194.2019.1574006

Clinical impact of Internet-based tools to guide therapeutic decisions for mantle cell lymphoma. / Gopalsamy, Srinivasa N.; Rosenthal, Kristen M.; Ayers, Amy A.; Goy, Andre; Leonard, John P.; Vose, Julie M.; Obholz, Kevin L.; Armitage, James O.; Flowers, Christopher R.

In: Leukemia and Lymphoma, Vol. 60, No. 9, 29.07.2019, p. 2255-2263.

Research output: Contribution to journalArticle

Gopalsamy, SN, Rosenthal, KM, Ayers, AA, Goy, A, Leonard, JP, Vose, JM, Obholz, KL, Armitage, JO & Flowers, CR 2019, 'Clinical impact of Internet-based tools to guide therapeutic decisions for mantle cell lymphoma', Leukemia and Lymphoma, vol. 60, no. 9, pp. 2255-2263. https://doi.org/10.1080/10428194.2019.1574006
Gopalsamy, Srinivasa N. ; Rosenthal, Kristen M. ; Ayers, Amy A. ; Goy, Andre ; Leonard, John P. ; Vose, Julie M. ; Obholz, Kevin L. ; Armitage, James O. ; Flowers, Christopher R. / Clinical impact of Internet-based tools to guide therapeutic decisions for mantle cell lymphoma. In: Leukemia and Lymphoma. 2019 ; Vol. 60, No. 9. pp. 2255-2263.
@article{b5dc8e6f29ad4592aa2867fe7863c0d1,
title = "Clinical impact of Internet-based tools to guide therapeutic decisions for mantle cell lymphoma",
abstract = "Mantle cell lymphoma (MCL) is a rare cancer with diverse management options. Although clinical practice guidelines have become ubiquitous across medicine, the utility of guidelines for MCL management is limited by provider awareness and the lack of a definitive standard of care. We sought to determine whether expert recommendations, delivered as an online decision support tool, impacted practitioners’ therapeutic decisions with MCL. Participants were more likely than the experts to select aggressive regimens for both newly diagnosed and relapsed/refractory MCL. After seeing the expert recommendations, participants revealed that the expert opinion impacted their treatment choices in 103 of 365 clinical scenarios, suggesting that online decision support tools may increase the number of clinicians making treatment decisions for patients with MCL that are concordant with expert consensus recommendations.",
keywords = "Mantle cell lymphoma, clinical decision support, decision making",
author = "Gopalsamy, {Srinivasa N.} and Rosenthal, {Kristen M.} and Ayers, {Amy A.} and Andre Goy and Leonard, {John P.} and Vose, {Julie M.} and Obholz, {Kevin L.} and Armitage, {James O.} and Flowers, {Christopher R.}",
year = "2019",
month = "7",
day = "29",
doi = "10.1080/10428194.2019.1574006",
language = "English (US)",
volume = "60",
pages = "2255--2263",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "9",

}

TY - JOUR

T1 - Clinical impact of Internet-based tools to guide therapeutic decisions for mantle cell lymphoma

AU - Gopalsamy, Srinivasa N.

AU - Rosenthal, Kristen M.

AU - Ayers, Amy A.

AU - Goy, Andre

AU - Leonard, John P.

AU - Vose, Julie M.

AU - Obholz, Kevin L.

AU - Armitage, James O.

AU - Flowers, Christopher R.

PY - 2019/7/29

Y1 - 2019/7/29

N2 - Mantle cell lymphoma (MCL) is a rare cancer with diverse management options. Although clinical practice guidelines have become ubiquitous across medicine, the utility of guidelines for MCL management is limited by provider awareness and the lack of a definitive standard of care. We sought to determine whether expert recommendations, delivered as an online decision support tool, impacted practitioners’ therapeutic decisions with MCL. Participants were more likely than the experts to select aggressive regimens for both newly diagnosed and relapsed/refractory MCL. After seeing the expert recommendations, participants revealed that the expert opinion impacted their treatment choices in 103 of 365 clinical scenarios, suggesting that online decision support tools may increase the number of clinicians making treatment decisions for patients with MCL that are concordant with expert consensus recommendations.

AB - Mantle cell lymphoma (MCL) is a rare cancer with diverse management options. Although clinical practice guidelines have become ubiquitous across medicine, the utility of guidelines for MCL management is limited by provider awareness and the lack of a definitive standard of care. We sought to determine whether expert recommendations, delivered as an online decision support tool, impacted practitioners’ therapeutic decisions with MCL. Participants were more likely than the experts to select aggressive regimens for both newly diagnosed and relapsed/refractory MCL. After seeing the expert recommendations, participants revealed that the expert opinion impacted their treatment choices in 103 of 365 clinical scenarios, suggesting that online decision support tools may increase the number of clinicians making treatment decisions for patients with MCL that are concordant with expert consensus recommendations.

KW - Mantle cell lymphoma

KW - clinical decision support

KW - decision making

UR - http://www.scopus.com/inward/record.url?scp=85062800471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062800471&partnerID=8YFLogxK

U2 - 10.1080/10428194.2019.1574006

DO - 10.1080/10428194.2019.1574006

M3 - Article

C2 - 30848966

AN - SCOPUS:85062800471

VL - 60

SP - 2255

EP - 2263

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 9

ER -